{"cmr":"ca-cm-kg/TSXV/MRVL","since":null,"total":15,"cursor":0,"limit":50,"next_cursor":null,"events":[{"cmr":"ca-cm-kg/TSXV/MRVL","date":"2026-10-19","event_type":"newswire_release","title":"Marvel Biosciences Advances MB-204 Toward First-in","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/10/19/3383228/0/en/marvel-biosciences-advances-mb-204-toward-first-in-human-testing-selects-cmax-as-phase-i-clinical-trial-site.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"6mijIiZHvdASE7MuIoHxUIZCjEfxWzIUG_xpq_i2TLMNgvcE5LCVPu0cucWEM3Obij9ZgC_rolpHGvT7Gl9MDw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSXV/MRVL","date":"2026-10-08","event_type":"exchange_bulletin","title":"TSXV bulletin: PP-N-B (Financings that are not done thru an Exchange Offering Prospectus)","source":"TSX Venture Exchange bulletin","url":"http://apps.tmx.com/TSXVenture/TSXVentureHttpController?GetPage=NoticesContents&PO_ID=&NOTICE_ID=321950&CORRECTION_FLG=N&HC_FLAG1=checked","read_by":"apps.tmx.com TSXV company documents","detail":"Financings that are not done thru an Exchange Offering Prospectus / PP-N-B","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"Yc1cKvLBxlQKw9PT7dFb-9jG2bTi7ZYUudX7MLAjBTskb1ZiANENC8Nxq9heC25_vARcyIN5GKYvvZ62er5eBQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSXV/MRVL","date":"2026-10-08","event_type":"newswire_release","title":"Marvel Biosciences Reports MB-204 as Highly Effective at","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/10/08/3377091/0/en/marvel-biosciences-reports-mb-204-as-highly-effective-at-treating-autism-behaviours-in-shank3-mouse-model.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"fsZ1rXrm0wCf0Dgf02Z99sNqDVg32tABleqQyuvY9xdZVuGtowh8WanlUXp5bU-biZwVtx7gAoeE3LX1lfgSDA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSXV/MRVL","date":"2026-10-06","event_type":"newswire_release","title":"Marvel Biosciences Signs Letter of Intent with Novatech for","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/10/06/3375295/0/en/marvel-biosciences-signs-letter-of-intent-with-novatech-for-phase-1-trial-of-mb-204-and-provides-corporate-update.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"L4bIOjOCWkyUb-Z8O11RO9lfvxJO2q_FIvmwG0zGekimBWUKWM76nkaD3SAZLspOTcIxRrX-oVF1z8pJmAkPBA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSXV/MRVL","date":"2026-09-17","event_type":"newswire_release","title":"Marvel Biosciences fait le point sur un placement privé ...","wire":"Newsfile","source":"Newsfile","url":"https://www.newsfilecorp.com/release/314827/Marvel-Biosciences-fait-le-point-sur-un-placement-priv-pouvant-atteindre-3-millions-de-dollars","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"Fl5sFXpjB3t0khXxgqIFS1_MdbUelzFxITF24Wc4Y4w2YDolyHjNm3Ri3pdXmKuOdcwPYc_rq2V1NOU2PkN-Ag","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSXV/MRVL","date":"2026-09-10","event_type":"newswire_release","title":"Marvel Biosciences annonce la prolongation de la date limite de ...","wire":"Newsfile","source":"Newsfile","url":"https://www.newsfilecorp.com/release/313683/Marvel-Biosciences-annonce-la-prolongation-de-la-date-limite-de-clture-du-placement-priv","read_by":"Tavily search (newsfilecorp.com) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"rrKojeJirW10hVU3skDZH_GpTm7bZllPdeS3E2NDCfZEq6RzS3nq9KiXdIBrNhi13xKk_qcHJxy8Vxtqk39LAQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSXV/MRVL","date":"2026-09-09","event_type":"newswire_release","title":"Marvel Biosciences Announces Extension to Closing Date of Private Placement","wire":"Newsfile","source":"Newsfile","url":"https://www.newsfilecorp.com/release/313681/Marvel-Biosciences-Announces-Extension-to-Closing-Date-of-Private-Placement","read_by":"Tavily search (newsfilecorp.com) + dateline in indexed snippet","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"6fWmMHnqK3QELgYZiQhUmnXAKws_iOuxXQBopoZ97gV8kaZj-0LOqPZCcX-pxZVnVJlAbjRi5W3sHCwQa7gbDA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSXV/MRVL","date":"2026-08-05","event_type":"newswire_release","title":"Marvel Biosciences Reports Positive Preclinical Data","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/08/05/3339079/0/en/marvel-biosciences-reports-positive-preclinical-data-demonstrating-mb-204-reverses-behavioural-and-cognitive-deficits-in-a-mouse-model-of-fragile-x.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"6pgVSRCDhIojP6hpd_urpaN9cHE838m-SqFggYNLObs51dJCC2E6YpPLcX_YZT6115NpWqA9uX1feHmYfjtKCQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSXV/MRVL","date":"2026-06-08","event_type":"newswire_release","title":"Marvel Biosciences Receives Notice of Allowance for","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/06/08/3307939/0/en/marvel-biosciences-receives-notice-of-allowance-for-australian-patent-application-covering-composition-of-matter-for-its-lead-therapeutic-candidate-mb-204.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"8XQYw38DVZEOoCsITHqsU37_i6T5zrk7Nj-7QUf87zWeRQXvGRanBuYrYKc1nh3GTYN7zVaE4UYDJLjcf4GVCw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSXV/MRVL","date":"2026-04-29","event_type":"exchange_bulletin","title":"TSXV bulletin: PP-N-B (Financings that are not done thru an Exchange Offering Prospectus)","source":"TSX Venture Exchange bulletin","url":"http://apps.tmx.com/TSXVenture/TSXVentureHttpController?GetPage=NoticesContents&PO_ID=&NOTICE_ID=317041&CORRECTION_FLG=N&HC_FLAG1=checked","read_by":"apps.tmx.com TSXV company documents","detail":"Financings that are not done thru an Exchange Offering Prospectus / PP-N-B","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"T2ieHOAFVYhg4fVbnL4Kcnrij_OJX_AonikgpPOj_l9GQgw3kHHdxY9Es0Iqw6RM4rEfu1iMDdkRvZcF8n6uAQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSXV/MRVL","date":"2026-04-23","event_type":"newswire_release","title":"Marvel Biosciences to Participate and Present at the 2nd","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/04/23/3279779/0/en/marvel-biosciences-to-participate-and-present-at-the-2nd-neuroscience-innovation-partnering-and-licensing-summit.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"UU6zDBDA5aMR9-6P8thvkLkAKiCk8pP1b813fmTlatHVW8MXVL8xJQR_8ZuZ52LoetqyormrUQZ6it_M6RDdAg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSXV/MRVL","date":"2026-04-16","event_type":"newswire_release","title":"Marvel Biosciences Identifies Liquid Formulations for - GlobeNewswire","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/04/16/3275184/0/en/marvel-biosciences-identifies-liquid-formulations-for-neurodevelopmental-disorders.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"HOqeH4VYYQj6Ic2SZgW1bPrmcSZlmChVLpbMWvfFMLKmdxJW5TzD7TW7nkqDn-uiBirs-fb_6Nizs3ZC8O1vAQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSXV/MRVL","date":"2026-04-07","event_type":"newswire_release","title":"Marvel Biosciences Secures Financial and Strategic - GlobeNewswire","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/04/07/3268993/0/en/marvel-biosciences-secures-financial-and-strategic-investment-with-5-horizon-ventures.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"GfrqfK9_lBMcrR-8UCsyAuGrEB49wumMIVex7Kx2RRGY7CEk2Dgf7Gb_UEXPaEdQiXe9cecnhLGUXRTy_YolDQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSXV/MRVL","date":"2026-03-30","event_type":"newswire_release","title":"Marvel Biosciences Secures Alberta Innovates Funding to","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/03/30/3264518/0/en/index.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"5qIRdgqhPrk9pLMDdUrC7kHCFEhKyFryX2GZzUtnyEzfiIDsO56PPJtAhDpanGwY1miXKZ0pvbAE7kwO41t_Bw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSXV/MRVL","date":"2026-03-25","event_type":"newswire_release","title":"Marvel Biosciences Selects Novotech as CRO for Its Phase I","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/03/25/3262086/0/en/marvel-biosciences-selects-novotech-as-cro-for-its-phase-i-clinical-trial-of-mb-204.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"W0TdCzEuKaoWIiLVglQTuBahdHy8EMakjVSbzxr-GrnN_hBQVfCA7Q7iz4BzHDAnv1E-T1lTiduejNi00gqPCg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}}],"events_signed":"allooloo-cmr-2026-10"}